Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Again I ask-where is the new news?

From CARLSBAD, Calif., April 26, 2010--(PR Newswire)-

On April 20, 2010 the Management Committee of PDS passed resolutions specifying that (i) any and all future licenses of the MMP Patent Portfolio must be approved in writing by a majority of the members of the Management Committee before they are agreed to or signed by TPL and (ii) effective immediately, TPL must not market patent portfolios in which PDS does not have an interest with the MMP Patent Portfolio. The TPL representative on the PDS Management Committee voted against the resolutions, and TPL has not expressed its acquiescence to the resolutions.

From the Press Release 2-3-2011

TPL has also agreed to increased involvement of Patriot in the oversight of the MMP Portfolio activities

From 10Q (filed 1-14-2011)

At Jan 13, 2011 PDS cash and cash equivalents were $7,007,897 is this not for the period covering Dec and Jan?

During the three months ended November 30, 2010 TPL entered into licensing agreements with third parties, pursuant to which PDS received aggregate proceeds of $1,409,000

From the Press Release 2-3-2011

Carlsbad, CA and Cupertino, CA - February 3, 2011 - Patriot Scientific Corporation (OTC Bulletin Board: PTSC News), The TPL Group, and Alliacense announced today that during December 2010 and January 2011, MMP Patent Portfolio licenses were entered into with several companies in the telecommunications and industrial equipment industry segments

From 10Q (filed 1-14-2011)

We and TPL are obligated to fund future working capital requirements at the discretion of the management committee of PDS in order to maintain working capital of not more than $8,000,000.

From the Press Release 2-3-2011

Earlier this month Patriot and TPL resolved a number of issues that arose over the past year related to the licensing and litigation activities of the MMP Patent Portfolio. The resolution included an agreement to provide a substantial increase in working capital for the MMP licensing program and patent infringement litigation from MMP licensing proceeds.

Share
New Message
Please login to post a reply